New mesothelioma drug turns cancer’s own defenses against it
Scientists are testing a counterintuitive way to fight mesothelioma, an aggressive asbestos-linked cancer with few effective treatments. A new experimental mesothelioma drug kills cancer cells by disabling PRX3, an antioxidant defense that tumors use to survive intense oxidative stress. In an early clinical trial, it controlled disease progression in 67% of patients and produced encouraging survival results, raising hopes that the strategy could eventually be used against other cancers.
The science section covers breakthroughs in medicine, physics, biology, and technology. We surface discoveries that expand what humanity can do, from new treatments reaching clinical trials to engineering feats that seemed impossible a decade ago. Every link goes to the original publisher so you can read the full study or press release yourself.
If today's breakthrough story sparked something, a live 1-on-1 tutor can take you from curious to competent. First lesson guaranteed or your money back.
Try Preply free →
BY THE OPTIMIST DAILY EDITORIAL TEAM Research has put a number on the value of a good hobby: eight hours. That is how mu…
BY THE OPTIMIST DAILY EDITORIAL TEAM The old cues for spotting a scam are becoming unreliable. Misspelled words, strange…
BY THE OPTIMIST DAILY EDITORIAL TEAM In 2019, a South American transport company ordered a diesel ferry. By the time it …
Credit: NASA NASA has selected SpaceX to provide launch services for the agency’s StarBurst mission, a small satellite d…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →